--- Query Results --- | |||
| Organization: | Alberta Precision Laboratories | ||
| Message Alert: | PLEASE NOTE: This Test Directory is in an interim state and due to changes pertaining to the DynaLIFE transition, performing site for routing has not been updated. Please refer to Laboratory Information System for appropriate routing. | ||
| Test Name/Synonym: | Anti-Glutamic Acid Decarboxylase, CSF (Synonym: Anti GAD, GAD65, GAD65 Antibodies, Glutamic Acid Decarboxylase, Islet Cell Antibody) | ||
| Clinical Indications: | GAD65 antibodies may help confirm a diagnosis of stiff-person syndrome, autoimmune encephalitis, autoimmune epilepsy, or autoimmune myelopathy. | ||
| LABID (Connect Care): | LAB5130 | ||
| Specimen Type: | Cerebrospinal Fluid | ||
| Primary Container: | Sterile container | ||
| Minimum Collection Volume: | 0.25 mL CSF | ||
| Test Resources: |
| ||
| Processing: | Centrifuge and remove supernatant from any cells present. Freeze immediately. | ||
| Transportation: | Transport frozen | ||
| Method: | Enzyme-linked Immunosorbent Assay (ELISA) | ||
| Testing Schedule: | Batched - test performed within 2 weeks of receipt | ||
| Reference Interval: | Negative: Less than 5.0 IU/mL | ||
| Testing Area: | Biochemistry | ||
| Performing Site: | University of Alberta Hospital | ||
| Additional Test Information: | This test is performed by Edmonton Special Chemistry | ||
| Last Updated On: | Thursday, June 20, 2024 | ||
